We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ANIP market cap is 1.26B. The company's latest EPS is USD 0.8157 and P/E is 73.41.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 132.39M | 131.65M | 137.43M | 138.04M | 148.33M |
| Operating Income | 15.95M | 8.71M | 15.06M | 5.53M | -11.4M |
| Net Income | 9.53M | 749k | 17.8M | -2.69M | -24.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 206.55M | 208.48M | 216.14M | 316.39M | 486.82M |
| Operating Income | 16.35M | -16.02M | -39.79M | -35.28M | 48.4M |
| Net Income | 6.09M | -22.55M | -42.79M | -49.52M | 17.15M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 889.91M | 904.42M | 914.52M | 920.75M | 1.29B |
| Total Liabilities | 435.2M | 446.82M | 437.71M | 440.14M | 856.58M |
| Total Equity | 429.86M | 432.75M | 451.96M | 455.76M | 405.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 456.79M | 461.19M | 771.6M | 760.09M | 904.42M |
| Total Liabilities | 244M | 265.49M | 412.86M | 421.55M | 446.82M |
| Total Equity | 212.79M | 195.7M | 333.89M | 313.69M | 432.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 74.22M | 118.96M | 18.27M | 35.68M | 48.16M |
| Investing | -13.73M | -18.51M | 8.93M | 4.48M | -394.04M |
| Financing | 79.36M | 67.44M | -19.73M | -21.18M | 269.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 45.63M | 15.27M | 3.32M | -31.2M | 118.96M |
| Investing | -27.55M | -68.32M | -105.48M | -15.74M | -18.51M |
| Financing | 1.25M | -1.44M | 194.6M | -5.13M | 67.44M |
| Market Cap | 1.26B |
| Price to Earnings Ratio | 73.41 |
| Price to Sales Ratio | 2.59 |
| Price to Cash Ratio | 5.69 |
| Price to Book Ratio | 2.75 |
| Dividend Yield | - |
| Shares Outstanding | 21.03M |
| Average Volume (1 week) | 132.97k |
| Average Volume (1 Month) | 180.52k |
| 52 Week Change | 8.59% |
| 52 Week High | 70.81 |
| 52 Week Low | 52.50 |
| Spread (Intraday) | 13.02 (18.63%) |
| Company Name | ANI Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.anipharmaceuticals.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
